| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011633405 |
| P356 | DOI | 10.1186/1471-2172-12-35 |
| P932 | PMC publication ID | 3124423 |
| P698 | PubMed publication ID | 21645356 |
| P5875 | ResearchGate publication ID | 51195539 |
| P50 | author | Fabian Benencia | Q55071808 |
| P2093 | author name string | Maria Muccioli | |
| Maria C Courreges | |||
| Leslee Sprague | |||
| Michelle Pate | |||
| Omowaleola Omosebi | |||
| John McGinty | |||
| Harika Nandigam | |||
| Amritha K Venkatesh | |||
| Andrew Rutowski | |||
| Evan Meles | |||
| Kristen Mansfield | |||
| Ming-Yu Gu | |||
| P2860 | cites work | Heparanase induces endothelial cell migration via protein kinase B/Akt activation | Q24320221 |
| The biology of VEGF and its receptors | Q27860704 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies | Q28592715 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| The role of myeloid cells in the promotion of tumour angiogenesis | Q29614299 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors | Q29618425 | ||
| Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques | Q33205809 | ||
| Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. | Q43955099 | ||
| HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer | Q44499920 | ||
| Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation | Q45195923 | ||
| Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation. | Q45395292 | ||
| Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions | Q47863833 | ||
| Influence of extracellular matrix proteins on the development of cultured human dendritic cells | Q48035769 | ||
| Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. | Q51737378 | ||
| The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation. | Q53329394 | ||
| Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. | Q54001580 | ||
| Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain | Q60678255 | ||
| Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes | Q67690190 | ||
| Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
| TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity | Q73075512 | ||
| Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function | Q73121472 | ||
| Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells | Q73521253 | ||
| Differences in angiogenic potential of classically vs alternatively activated macrophages | Q73980573 | ||
| Adhesion molecules are upregulated on dendritic cells isolated from human blood | Q73985178 | ||
| Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF | Q74817245 | ||
| Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis | Q80040330 | ||
| Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer | Q80458732 | ||
| Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A | Q80501633 | ||
| Vascular leukocytes contribute to tumor vascularization | Q80546906 | ||
| Subpopulations of human dendritic cells display a distinct phenotype and bind differentially to proteins of the extracellular matrix | Q80775172 | ||
| Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma | Q81859838 | ||
| Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus | Q82639445 | ||
| Integrins | Q84435469 | ||
| Dendritic cells augment choroidal neovascularization | Q33327945 | ||
| Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation | Q33757576 | ||
| Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response. | Q33869476 | ||
| The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics | Q34282306 | ||
| Vascular endothelial growth factor: basic science and clinical progress | Q34549887 | ||
| Mechanisms of normal and tumor-derived angiogenesis | Q34592513 | ||
| Nanomolecular targeting of dendritic cells for ovarian cancer therapy | Q34663940 | ||
| UVB-irradiated dendritic cells induce nonproliferating, regulatory type T cells | Q34869439 | ||
| Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q35694224 | ||
| Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. | Q35748149 | ||
| Cancer immunotherapy with mRNA-transfected dendritic cells | Q35826417 | ||
| Monocytes form a vascular barrier and participate in vessel repair after brain injury | Q35849990 | ||
| The role of dendritic cell precursors in tumour vasculogenesis. | Q36078034 | ||
| Bone marrow-derived cells in mouse and human cornea | Q36287790 | ||
| VEGF as a therapeutic target in cancer | Q36319029 | ||
| Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody | Q36376567 | ||
| Targeting tumours by adoptive transfer of immune cells | Q36478870 | ||
| Generation, migration and function of circulating dendritic cells | Q36507785 | ||
| Dendritic cell-endothelial cell cross-talk in angiogenesis | Q36907764 | ||
| Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. | Q36944354 | ||
| Modulation of the immune response using dendritic cell-derived exosomes | Q36944603 | ||
| The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages | Q36959353 | ||
| T-cell costimulation and coinhibition in atherosclerosis. | Q37143018 | ||
| Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity | Q37286656 | ||
| Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. | Q37342848 | ||
| Mechanisms of murine dendritic cell antitumor dysfunction in aging | Q37350766 | ||
| The role of fibroblast growth factors in tumor growth | Q37512303 | ||
| PSGL-1 function in immunity and steady state homeostasis | Q37548631 | ||
| Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. | Q37621566 | ||
| Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration | Q37727092 | ||
| Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. | Q38973017 | ||
| Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. | Q40031362 | ||
| Endothelial-like cells derived from human CD14 positive monocytes. | Q40863903 | ||
| Development of a syngeneic mouse model for events related to ovarian cancer | Q40888613 | ||
| The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. | Q42080528 | ||
| Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients | Q42742001 | ||
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 35 | |
| P577 | publication date | 2011-06-06 | |
| P1433 | published in | BMC Immunology | Q2877163 |
| P1476 | title | The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells | |
| P478 | volume | 12 |
| Q41097226 | Absence of immune responses with xenogeneic collagen and elastin |
| Q36146867 | Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. |
| Q36798288 | Astrocytes inhibit microglial surface expression of dendritic cell-related co-stimulatory molecules through a contact-mediated process |
| Q38021625 | Dendritic cells and their role in tumor immunosurveillance |
| Q38002844 | Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination |
| Q39020907 | Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments. |
| Q40496381 | Enhanced Cell Growth of Adipocyte-Derived Mesenchymal Stem Cells Using Chemically-Defined Serum-Free Media |
| Q34532767 | Fast-proliferating adipose tissue mesenchymal-stromal-like cells for therapy |
| Q30843339 | Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation |
| Q28392156 | Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models |
| Q33632038 | Ovarian dendritic cells act as a double-edged pro-ovulatory and anti-inflammatory sword |
| Q26830839 | Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies |
| Q27313463 | Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization |
| Q35641614 | To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices. |
Search more.